Achieving our aspiration to cure #cancer requires close collaboration both internally and with those beyond the walls of Takeda. By working together as a collective #oncology ecosystem, we can more effectively address the needs of people living with cancer. View Pallavi Garg’s interview with PhRMA, in which she discusses the transformative promise of partnerships: https://lnkd.in/enVrcQJW
About us
Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited, is structured to ensure a tight connection from research to development to commercialization and rapidly meet the needs of the cancer community, optimizing our ability to bring transformative medicines to market. Built on a legacy foundation and structured for agility, our leaders have proven experience to drive future growth. We’ve demonstrated leadership in the treatment of hematologic cancers and solid tumors, and we’re now leveraging that expertise to advance cutting-edge science through multiple platforms, partnerships and therapeutic approaches. We are focused on collaborating with leading scientific teams around the globe to accelerate remarkable innovation, including by leveraging the power of innate immunity to enhance and broaden the impact of immunotherapy. We complement our deep in-house expertise with a network of symbiotic external partnerships to unlock the most promising science wherever it emerges. We fuel our relationships with academic, biotechnology and pharmaceutical partners with mutual respect, shared knowledge, scientific rigor and agility to find the best way to attack cancer. Takeda Oncology: We aspire to cure cancer, with inspiration from patients and innovation from everywhere. For more information, visit www.takedaoncology.com. If you are interested in learning more about current career opportunities, please visit the Takeda Pharmaceuticals Career Page. Review our social media community guidelines: https://www.takedaoncology.com/social-media-policy/
- Website
-
http://www.takedaoncology.com
External link for Takeda Oncology
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, MA
- Type
- Public Company
- Founded
- 1993
- Specialties
- oncology, drug development, and biotechnology
Locations
-
Primary
40 Landsdowne St.
Cambridge, MA 02139, US
Employees at Takeda Oncology
Updates
-
Today at BioTechX EU, our own Philipp Pauli, Country Head Germany, and other industry leaders led a panel discussion about the role of Big Data in #oncology. Thanks to the innovative work of people like Philipp, #TeamTakeda continues to make advancements in predictive analytics, using big data to forecast disease progression and treatment responses to help improve the patient experience. #BioTechX
Happy to share I have been hosting today’s track Big Data in Oncology at @BioTechX EU 24 conference https://lnkd.in/eAUPUKz9. Together with so many inspiring speakers we took a closer look at data-driven Oncology and how AI aims to transform precision oncology, clinical studies and personalized therapies. Honor to chair this amazing track and many thanks to all speakers involved here! #BioTechX #BigDataInOncology Thomas Hufener Christophe Dufour Georgia Chan Jean-Pierre Hubaux Jacob Reimers Jon Teague Shayoni Dutta Mieke Van Hemelrijck Mike Rossi Karl Smith Byrne
-
This #BloodCancerAwarenessMonth, #TeamTakeda wore red in solidarity with the #BloodCancer community. Swipe to see how our team put blood cancer awareness in the spotlight to call attention to the urgent need for more action.
-
Next month, our own Philipp Pauli, Country Head Germany, will host the Big Data in Oncology panel discussion during the BioTechX EU conference on October 9th in Basel, Switzerland. Want to hear Philipp’s thoughts on big data and the latest in multiomic data management and personalized therapies ahead of the conference? Read his interview here: https://lnkd.in/e6CUHjeZ #BioTechX #BigDataInOncology
-
This past weekend, #TeamTakeda joined 400+ riders for Clip In 4 the Cure in Nashville, Tennessee, united in one purpose: cycling to fight for a world without #cancer. We are proud to have been a key sponsor for this event transforming the future of cancer research and care!
-
Join us at the ESMO - European Society for Medical Oncology Annual Meeting for a Takeda Oncology-sponsored medical symposium to hear the latest from #oncology leaders on navigating treatment selection for people living with metastatic colorectal cancer (#mCRC). View details on this Saturday’s symposium here: https://lnkd.in/gcnc636q #ESMO24 #crcsm
-
We had a great time at the Pan-Mass Challenge this weekend. Thank you to our riders for cycling to cure cancer, all our colleagues who volunteered and to those who cheered us on! See #TeamTakeda in action at #PMC2024 below!
-
We are pleased to enter a new partnership with BostonGene, a leading provider of #ArtificialIntelligence (AI)-driven molecular and immune profiling solutions. This partnership will enable us to use cutting-edge technology to better understand our investigational therapies at the earliest stages, optimizing their development for people living with #cancer. Find out more: https://lnkd.in/g3kJes6f
-
#TeamTakeda is back on the road for the 2024 Pan-Mass Challenge! Hear why representing #TeamTakeda at the #PMC2024 is more than just a ride for Julie. #OneInABillion #WhyIRide
For team members like Julie, riding with #TeamTakeda allows her to embrace two important identities within the #cancer community as both a dedicated professional and caring family member. Hear why she's proud to honor her brother Ryan at this year’s Pan-Mass Challenge. #PMC2024 | #OneInABillion
-
We’re pleased to share the European Commission has approved a therapy for adult patients with previously treated metastatic #ColorectalCancer (#mCRC) throughout the European Union, Iceland, Liechtenstein and Norway. Learn more about this announcement: https://lnkd.in/gJjVNcut